These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37122097)

  • 1. Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy.
    Luciani M; Montalbano M; Troncone L; Bacchin C; Uchida K; Daniele G; Jacobs Wolf B; Butler HM; Kiel J; Berto S; Gensemer C; Moore K; Morningstar J; Diteepeng T; Albayram O; Abisambra JF; Norris RA; Di Salvo TG; Prosser B; Kayed R; Del Monte F
    Eur Heart J; 2023 May; 44(17):1560-1570. PubMed ID: 37122097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tau-induced neurodegeneration.
    Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
    Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
    McMillan PJ; Benbow SJ; Uhrich R; Saxton A; Baum M; Strovas T; Wheeler JM; Baker J; Liachko NF; Keene CD; Latimer CS; Kraemer BC
    Brain; 2023 Aug; 146(8):3206-3220. PubMed ID: 36732296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation.
    Li L; Miao J; Chu D; Jin N; Tung YC; Dai CL; Hu W; Gong CX; Iqbal K; Liu F
    CNS Neurosci Ther; 2022 Dec; 28(12):2245-2259. PubMed ID: 36114722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating Tau function and dysfunction in the era of cryo-EM.
    Lippens G; Gigant B
    J Biol Chem; 2019 Jun; 294(24):9316-9325. PubMed ID: 31088912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau and Alzheimer's disease: Past, present and future.
    Iqbal K
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):116-121. PubMed ID: 38126608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tau in Alzheimer's disease and related disorders.
    Medeiros R; Baglietto-Vargas D; LaFerla FM
    CNS Neurosci Ther; 2011 Oct; 17(5):514-24. PubMed ID: 20553310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
    Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
    J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
    Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE
    FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.